Literature DB >> 21135003

Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.

Sidharth Mahapatra1, Jonathan L Belgrad, Martins A Adeoye.   

Abstract

Drug-related eosinophilia with systemic symptoms (DRESS) is a potentially life-threatening, multiorgan condition that can result from drug treatment. Antiepileptic medications have provided the best-studied link of any class of medications. Here, we report the case of a 16-year-old boy with long-standing bipolar disorder who was chronically treated with aripiprazole and fluoxetine and developed DRESS syndrome after ingestion of high doses of caffeine. His classic presentation with fever, morbilliform rash, lymphadenopathy, and visceral involvement, including leukocytosis, eosinophilia, and hepatitis, was consistent with this diagnosis. Furthermore, the patient's symptoms dramatically improved after corticosteroid therapy and discontinuation of all psychotropic medications. We propose that the development of DRESS syndrome is a net result of inconsistent medication adherence coupled with the ingestion of near-toxic doses of caffeine, which can lead to rhabdomyolysis and, through renal impairment, lead to the accumulation of toxic oxidative metabolites of either or both psychotropic medications. We also present one of the few reported cases of caffeine-induced rhabdomyolysis and propose its role in the development of DRESS in this patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135003     DOI: 10.1542/peds.2010-0374

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  2 in total

1.  Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance.

Authors:  Rebecca B Saunderson; Roger Garsia; Alexander P Headley; Geoffrey W McCaughan; Sandra O'Toole; Simone I Strasser
Journal:  J Dermatol Case Rep       Date:  2013-09-30

2.  A case of drug reaction with eosinophilia and systemic symptoms.

Authors:  Sally Kellett; Charles Cock
Journal:  Case Rep Med       Date:  2012-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.